FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1970010312> ?p ?o ?g. }

• W1970010312 endingPage "1262" @default.
• W1970010312 startingPage "1258" @default.
• W1970010312 abstract "Background. Posttransplant hemolytic uremic syndrome (pHUS) is a rare but severe disorder that confers a poor prognosis on an allograft due to thrombotic microangiopathy. Immunosuppression with cyclosporine (CsA) is implicated as a significant risk factor for the development of pHUS. In early reports, it was hypothesized that immunosuppresion with FK506 (tacrolimus) would avoid the development of pHUS. However, this initially supposed beneficial effect remains controversial, because pHUS associated with tacrolimus therapy has been published in some later case reports. This article aims to further evaluate FK506 with respect to the development and resolution of pHUS. Methods. We describe the course of seven adult kidney graft recipients with pHUS, treated with FK506 either as initial immunosuppression for retransplantation or after discontinuation of CsA for resolution of pHUS. Work-up for pHUS was initiated when certain clinical features, such as hemolytic anemia, thrombocytopenia, and deterioration of graft function, were found. The diagnosis was confirmed by histologic examination of a renal allograft biopsy specimen (thrombotic microangiopathy). With the onset of pHUS, additional plasma exchange was performed in all patients. Results. Two patients suffered from end-stage renal disease due to primary HUS and had a history of recurrent pHUS in previous renal transplants. In both patients, the attempt to regraft was only made because of the early optimistic reports using FK506. Despite initial FK506 therapy, both recipients developed pHUS again, leading to loss of graft function. Two additional kidney graft recipients with primary renal failure other than HUS also received FK506 as initial immunosuppression. One of them (loss of the first kidney graft due to CsA-induced pHUS) was successfully treated with FK506 for his second renal transplant. The other recipient, a patient in whom de novo pHUS had occurred in the first graft despite initial therapy with FK506, was treated with CsA for his second graft and again developed pHUS. The latter process, however, could be reversed by a switch to steroids and azathioprine. In all three patients regrafted for reasons other than pHUS, development of de novo pHUS was treated by CsA withdrawal and a switch to FK506; this approach was effective in two patients. Conclusion. Our results demonstrate that three of seven renal allograft recipients benefited from FK506 therapy for prevention or resolution of pHUS. Treatment or prophylaxis with FK506 can be considered advantageous in some patients with de novo pHUS, but FK506 fails to prevent recurrent pHUS in patients with primary HUS." @default.
• W1970010312 created "2016-06-24" @default.
• W1970010312 creator A5038954546 @default.
• W1970010312 creator A5040144977 @default.
• W1970010312 creator A5047928303 @default.
• W1970010312 creator A5062922220 @default.
• W1970010312 creator A5086977298 @default.
• W1970010312 creator A5091560797 @default.
• W1970010312 date "1998-11-01" @default.
• W1970010312 modified "2023-10-17" @default.
• W1970010312 title "POSTTRANSPLANT HEMOLYTIC UREMIC SYNDROME IN ADULT RETRANSPLANTED KIDNEY GRAFT RECIPIENTS: ADVANTAGE OF FK506 THERAPY?" @default.
• W1970010312 cites W189932655 @default.
• W1970010312 cites W2046114120 @default.
• W1970010312 cites W2071011904 @default.
• W1970010312 cites W2078294084 @default.
• W1970010312 cites W2121454052 @default.
• W1970010312 cites W2139914076 @default.
• W1970010312 cites W4231743526 @default.
• W1970010312 cites W4235567234 @default.
• W1970010312 cites W4301887097 @default.
• W1970010312 doi "https://doi.org/10.1097/00007890-199811150-00024" @default.
• W1970010312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9825827" @default.
• W1970010312 hasPublicationYear "1998" @default.
• W1970010312 type Work @default.
• W1970010312 sameAs 1970010312 @default.
• W1970010312 citedByCount "30" @default.
• W1970010312 countsByYear W19700103122014 @default.
• W1970010312 countsByYear W19700103122015 @default.
• W1970010312 countsByYear W19700103122016 @default.
• W1970010312 countsByYear W19700103122021 @default.
• W1970010312 crossrefType "journal-article" @default.
• W1970010312 hasAuthorship W1970010312A5038954546 @default.
• W1970010312 hasAuthorship W1970010312A5040144977 @default.
• W1970010312 hasAuthorship W1970010312A5047928303 @default.
• W1970010312 hasAuthorship W1970010312A5062922220 @default.
• W1970010312 hasAuthorship W1970010312A5086977298 @default.
• W1970010312 hasAuthorship W1970010312A5091560797 @default.
• W1970010312 hasBestOaLocation W19700103121 @default.
• W1970010312 hasConcept C126322002 @default.
• W1970010312 hasConcept C128057223 @default.
• W1970010312 hasConcept C159641895 @default.
• W1970010312 hasConcept C2776175824 @default.
• W1970010312 hasConcept C2777878052 @default.
• W1970010312 hasConcept C2779134260 @default.
• W1970010312 hasConcept C2780252810 @default.
• W1970010312 hasConcept C2909675724 @default.
• W1970010312 hasConcept C2911091166 @default.
• W1970010312 hasConcept C71924100 @default.
• W1970010312 hasConcept C90924648 @default.
• W1970010312 hasConceptScore W1970010312C126322002 @default.
• W1970010312 hasConceptScore W1970010312C128057223 @default.
• W1970010312 hasConceptScore W1970010312C159641895 @default.
• W1970010312 hasConceptScore W1970010312C2776175824 @default.
• W1970010312 hasConceptScore W1970010312C2777878052 @default.
• W1970010312 hasConceptScore W1970010312C2779134260 @default.
• W1970010312 hasConceptScore W1970010312C2780252810 @default.
• W1970010312 hasConceptScore W1970010312C2909675724 @default.
• W1970010312 hasConceptScore W1970010312C2911091166 @default.
• W1970010312 hasConceptScore W1970010312C71924100 @default.
• W1970010312 hasConceptScore W1970010312C90924648 @default.
• W1970010312 hasIssue "9" @default.
• W1970010312 hasLocation W19700103121 @default.
• W1970010312 hasLocation W19700103122 @default.
• W1970010312 hasLocation W19700103123 @default.
• W1970010312 hasOpenAccess W1970010312 @default.
• W1970010312 hasPrimaryLocation W19700103121 @default.
• W1970010312 hasRelatedWork W2025321012 @default.
• W1970010312 hasRelatedWork W2039925961 @default.
• W1970010312 hasRelatedWork W2057461145 @default.
• W1970010312 hasRelatedWork W2064796437 @default.
• W1970010312 hasRelatedWork W2071345378 @default.
• W1970010312 hasRelatedWork W2114862870 @default.
• W1970010312 hasRelatedWork W2131605993 @default.
• W1970010312 hasRelatedWork W2317216770 @default.
• W1970010312 hasRelatedWork W2328505765 @default.
• W1970010312 hasRelatedWork W4385580458 @default.
• W1970010312 hasVolume "66" @default.
• W1970010312 isParatext "false" @default.
• W1970010312 isRetracted "false" @default.
• W1970010312 magId "1970010312" @default.
• W1970010312 workType "article" @default.